PNT Projected Dividend Yield
POINT Biopharma Global Inc ( NASDAQ : PNT )POINT Biopharma Global is a radiopharmaceutical company focusing on the clinical development and commercialization of radioligands for cancer treatment. Co.'s product candidates include: PNT2002, which is a prostate-specific membrane antigen (PSMA) targeted radioligand for the treatment of metastatic castration-resistant prostate cancer; PNT2004, which is a fibroblast activation protein-a targeting program being developed for use in several tumor types; PNT2003, which is a somatostatin-targeted radioligand in development for the treatment of neuroendocrine tumors; and PNT2001, which is a PSMA targeting ligand family that utilizes linker technology that promotes increased tumor accumulation. 20 YEAR PERFORMANCE RESULTS |
PNT Dividend History Detail PNT Dividend News PNT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |